Guidance Documents
Guidance Documents
Component | Document | Issued | Posted | ID | Topic | Overview |
---|---|---|---|---|---|---|
Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) | Advisory Opinion on Licensing for Certain Gun Show Sellers | February 18, 2016 | April 21, 2022 | DOJ-1980871 | Firearms |
This letter provides additional guidance on licensing for persons engaged in selling firearms at in-state gun shows. |
Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) | Explosives Licensees and Permittees: Voluntary Steps to Prepare for a Pending Natural Disaster (ATF P 5400.16) | March 1, 2011 | June 14, 2021 | DOJ-1980876 | Explosives |
This publication contians voluntary steps for federal explosives licensees and permittees to prepare for and recover from natural disasters. |
Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) | Federal Firearms Licensee Quick Reference and Best Practices Guide | Not specified | December 27, 2021 | DOJ-1981026 | Firearms |
This guide examines a list of the most common issues observed by ATF IOIs during ATF inspections. |
Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) | NICS Act List of Approved Programs download | July 9, 2021 | July 15, 2021 | DOJ-1981041 | Firearms |
The NICS Improvement Amendments Act of 2007 (NIAA) requires states, as a condition of grant eligibility, to establish procedures to allow persons with disabilities relating to mental health (i.e., prohibiting mental health adjudications or involuntary commitments to a mental institution) to obtain relief from such disabilities for purposes of firearms eligibility. |
Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) | Federal Firearms Licensee (FFL) Newsletter - June 2021 | June 1, 2021 | June 11, 2021 | DOJ-1981051 | Firearms |
What's in this issue: What is a Straw Purchase; Silencer Markings and Registration Requirements; Changes to ATF Form 4473; State of Residence and Identification; NICS Alternative Permits and Age Restrictions; and more. |
Civil Rights Division, Civil Rights - Disability Rights Section | Telehealth Guidance | July 29, 2022 | August 1, 2022 | DOJ-1989411 | Civil Rights |
This document explains how various federal nondiscrimination laws, including the Americans with Disabilities Act, Section 504 of the Rehabilitation Act of 1973, Title VI of the Civil Rights Act of 1964, and Section 1557 of the Patient Protection and Affordable Care Act, can help to ensure that services provided via telehealth are accessible to people with disabilities and limited English proficient persons. |
Civil Rights Division, Civil Rights - Disability Rights Section | Opioid Crisis Guidance | April 5, 2022 | August 1, 2022 | DOJ-1989446 | Civil Rights |
This guidance document addresses how the Americans with Disabilities Act protects people with opioid use disorder (OUD) who are in treatment or recovery, including those who take medication to treat their OUD. |
Civil Rights Division, Civil Rights - Disability Rights Section | COVID Q&A on Visitors | January 4, 2022 | August 1, 2022 | DOJ-1989476 | Civil Rights |
This Q&A addresses the intersection of heath care entities’ COVID-19 era “visitor” policies and their intersection with the entities’ existing ADA obligations. |
Civil Rights Division, Civil Rights - Disability Rights Section | COVID Q&A on Streateries | January 4, 2022 | August 1, 2022 | DOJ-1989486 | Civil Rights |
This Q&A addresses the Americans with Disabilities Act’s application to the many outdoor restaurants and retail spaces established due to COVID-19. |
Civil Rights Division, Civil Rights - Disability Rights Section | Guidance on Web Accessibility and the ADA | March 18, 2022 | August 1, 2022 | DOJ-1989491 | Civil Rights |
This guidance describes how state and local governments and businesses open to the public can make sure that their websites are accessible to people with disabilities as required by the Americans with Disabilities Act (ADA). |
Civil Rights Division, Civil Rights - Disability Rights Section | Long COVID Guidance | July 26, 2021 | August 1, 2022 | DOJ-1989496 | Civil Rights |
This guidance explains that long COVID can be a disability under Titles II and III of the Americans with Disabilities Act, Section 504 of the Rehabilitation Act of 1973, and Section 1557 of the Patient Protection and Affordable Care Act. This guidance also provides resources for additional information and best practices. |
Civil Rights Division, Civil Rights - Disability Rights Section | AI Guidance | May 12, 2022 | August 1, 2022 | DOJ-1989501 | Civil Rights |
A guidance document that provides a broad overview of how employers’ use of artificial intelligence, algorithms, and other technologies in hiring and employment may result in unlawful discrimination against people with disabilities under Title I of the Americans with Disabilities Act (ADA). |
Civil Rights Division, Civil Rights - Disability Rights Section, Civil Rights - Educational Opportunities Section | Supporting and Protecting the Rights of Students at Risk of Self-Harm in the Era of COVID-19 | October 13, 2021 | September 8, 2022 | DOJ-2004186 | Civil Rights |
This fact sheet, issued jointly with the Office for Civil Rights of the Department of Education, provides information about federal civil rights laws that protect students with mental health disabilities at risk of self-harm in the era of COVID-19. |
Diversion Control Program (DEA) | DEA-Registered Authorized Collector Reporting of Theft, Loss, or Missing Sealed Inner Liners that Occurs While in a Common or Co | September 13, 2022 | September 15, 2022 | DEA-DC-59 | DEA Records and Reports |
This guidance document addresses whether a Drug Enforcement Administration (DEA) registrant who is an authorized collector has the responsibility to file a Report of Theft or Loss of Controlled Substances (DEA Form 106) if a sealed inner liner is stolen, lost, or missing while in a common or contract carrier’s custody. |
Diversion Control Program (DEA) | Reporting Theft, Loss, or Missing Sealed Inner Liners from a Law Enforcement Agency | September 13, 2022 | September 15, 2022 | DEA-DC-60 | DEA Records and Reports |
This guidance document explains that a Federal, State, tribal, or local law enforcement agency has autonomy regarding the collection and disposal of controlled substances, and would not file a Report of Theft or Loss of Controlled Substances (DEA Form 106) with the Drug Enforcement Administration (DEA) if a sealed inner liner is stolen, lost, or missing from the law enforcement agency. |
Diversion Control Program (DEA) | Transportation of Sealed Inner Liners from or by DEA-Registered Authorized Collectors | September 13, 2022 | September 15, 2022 | DEA-DC-61 | DEA Records and Reports |
This guidance document addresses whether a sealed inner liner may be transported by employees of a Drug Enforcement Administration (DEA) registrant authorized as a collector, or after pick-up by a common courier driver, to a common carrier storefront/franchise prior to the common carrier transporting the sealed inner liner to a reverse distributor for destruction. |
Diversion Control Program (DEA) | Date of Receipt of Sealed Inner Liners by Reverse Distributors | September 13, 2022 | September 15, 2022 | DEA-DC-62 | DEA Records and Reports |
This guidance document addresses when a Drug Enforcement Administration (DEA)-registered reverse distributor is considered to have received a sealed inner liner from either a DEA registrant authorized as collectors or law enforcement. |
Drug Enforcement Administration (DEA) | Reporting Theft, Loss, or Missing Sealed Inner Liners from DEA-Registered Authorized Collector Locations | September 13, 1922 | September 20, 2022 | DEA-DC-58 | DEA Records and Reports |
This guidance document addresses whether a Drug Enforcement Administration (DEA) registrant who is an authorized collector has the responsibility to file a Report of Theft or Loss of Controlled Substances (DEA Form 106) if a sealed inner liner is stolen, lost, or missing from the collector’s registered location (or authorized long-term care facility) before the sealed inner liner is picked up for destruction or destroyed on-site. |
U.S. Trustee Program | Letter Concerning Debtor Education Certificates | October 13, 2022 | November 18, 2022 | UST-2032921 | Credit Counseling & Debtor Education (Bankruptcy) |
Letter to debtor education providers concerning the filing of debtor education certificates with the bankruptcy courts |
Drug Enforcement Administration (DEA) | Controlled Substances Act Pursuant to the Religious Freedom Restoration Act | February 26, 2018 | December 9, 2020 | DEA-DC-05 | General |
Guidance establishing a process for DEA decisions regarding requests for exemptions to handle controlled substances pursuant to the Religious Freedom Restoration Act (RFRA). (Revised 12-9-2020) |
Diversion Control Program (DEA) | Civil Unrest Q&A Theft and Loss | June 5, 2020 | June 12, 2020 | DEA-DC-33 | DEA Records and Reports |
Question and answer concerning reporting of theft and/or loss of controlled substances during civil unrest and looting. |
Diversion Control Program (DEA) | Civil Unrest Q&A: Moving of Controlled Substances (Practitioners) | June 9, 2020 | June 11, 2020 | DEA-DC-37 | DEA Registration |
Question and answer concerning practitioners needing to move controlled substances due to civil unrest and looting. |
Diversion Control Program (DEA) | Changes Pharmacists May Make to Schedule II Paper Prescriptions | October 18, 2022 | October 18, 2022 | DEA-DC-063 | Controlled Substance Prescriptions |
This guidance document provides clarification regarding the changes pharmacists may make to schedule II paper prescriptions. This guidance will remain in effect until the Drug Enforcement Administration (DEA) codifies new regulations, or until this guidance is otherwise modified or withdrawn by DEA. |
Diversion Control Program (DEA) | Can I use a PO Box as my Registered Location | December 9, 2020 | December 9, 2020 | DEA-DC-050 | DEA Registration |
This guidance document answers the question: “If a registrant may use a post office box or private mailbox address as the registered address.” |
Diversion Control Program (DEA) | Pharmacist Guide to Prescription Fraud | Not specified | February 28, 2020 | DEA-DC-02 | Controlled Substance Prescriptions |
This information alerts the reader to certain signs, behaviors or symptoms that the drug impaired co-worker may exhibit. The material discusses things such as absenteeism, frequent disappearances, not meeting deadlines and work performances alternating between low and high periods of productivity. The material also gives the reader what are his/her responsibilities and things they can do to help to co-worker. |